A patient receiving an angiotensin converting enzyme (ACE) inhibitor may experience an anaphylactoid reaction with hypotension when undergoing extracorporeal blood processing.
Pathogenesis: Kininogen may be activated by exposure to negatively-charged surfaces of an artificial blood processing filter, resulting in formation of bradykinin. ACE inhibitors inhibit kininase II, which delays bradykinin metabolism and results in increased plasma levels.
(1) transfusion of blood through leukocyte reduction filter
(4) plasma exchange
(5) Staphylococcal protein A affinity absorption
Prevention: ACE inhibitors should be stopped 24-48 hours prior to exposure.
To read more or access our algorithms and calculators, please log in or register.
Purpose: To evaluate a patient with an unexpected reaction during blood transfusion or processing associated with ACE inhibitor therapy.
Specialty: Clinical Laboratory
Objective: failure handling and therapy escalation, adverse effects
ICD-10: I10-I15, I50,